{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:31:46Z","timestamp":1793935906352,"version":"4.8.0"},"reference-count":52,"publisher":"BMJ","issue":"Suppl 2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2018,11,6]]},"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>\n                    <jats:styled-content style=\"text-color:#E4919F\">Diagnostics<\/jats:styled-content>\n                    are fundamental for successful outbreak containment. In this supplement, \u2018Diagnostic preparedness for WHO Blueprint pathogens\u2019, we describe specific diagnostic challenges presented by selected priority pathogens most likely to cause future epidemics.\n                  <\/jats:p>\n                  <jats:p>Some challenges to diagnostic preparedness are common to all outbreak situations, as highlighted by recent outbreaks of Ebola, Zika and yellow fever. In this article, we review these overarching challenges and explore potential solutions. Challenges include fragmented and unreliable funding pathways, limited access to specimens and reagents, inadequate diagnostic testing capacity at both national and community levels of healthcare and lack of incentives for companies to develop and manufacture diagnostics for priority pathogens during non-outbreak periods. Addressing these challenges in an efficient and effective way will require multiple stakeholders\u2014public and private\u2014coordinated in implementing a holistic approach to diagnostics preparedness. All require strengthening of healthcare system diagnostic capacity (including surveillance and education of healthcare workers), establishment of sustainable financing and market strategies and integration of diagnostics with existing mechanisms. Identifying overlaps in diagnostic development needs across different priority pathogens would allow more timely and cost-effective use of resources than a pathogen by pathogen approach; target product profiles for diagnostics should be refined accordingly. We recommend the establishment of a global forum to bring together representatives from all key stakeholders required for the response to develop a coordinated implementation plan. In addition, we should explore if and how existing mechanisms to address challenges to the vaccines sector, such as Coalition for Epidemic Preparedness Innovations and Gavi, could be expanded to cover diagnostics.<\/jats:p>","DOI":"10.1136\/bmjgh-2018-001179","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T23:08:32Z","timestamp":1548889712000},"page":"e001179","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":134,"title":["Importance of diagnostics in epidemic and pandemic preparedness"],"prefix":"10.1136","volume":"4","author":[{"given":"Cassandra D","family":"Kelly-Cirino","sequence":"first","affiliation":[{"name":"Foundation for Innovative New Diagnostics, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Nkengasong","sequence":"additional","affiliation":[{"name":"Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Kettler","sequence":"additional","affiliation":[{"name":"Bill & Melinda Gates Foundation, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Tongio","sequence":"additional","affiliation":[{"name":"BioM\u00e9rieux, Marcy l\u2019Etoile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Gay-Andrieu","sequence":"additional","affiliation":[{"name":"BioM\u00e9rieux, Marcy l\u2019Etoile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Escadafal","sequence":"additional","affiliation":[{"name":"Foundation for Innovative New Diagnostics, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Piot","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna W","family":"Peeling","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Gadde","sequence":"additional","affiliation":[{"name":"Becton Dickinson (BD), Franklin Lakes, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Boehme","sequence":"additional","affiliation":[{"name":"Foundation for Innovative New Diagnostics, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"key":"2025073015115255000_4.Suppl_2.e001179.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30458-6"},{"key":"2025073015115255000_4.Suppl_2.e001179.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31224-2"},{"key":"2025073015115255000_4.Suppl_2.e001179.3","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0140-6736(18)30308-8","article-title":"Laboratory medicine in low-income and middle-income countries: progress and challenges","volume":"391","author":"Nkengasong","year":"2018","journal-title":"Lancet"},{"key":"2025073015115255000_4.Suppl_2.e001179.4","unstructured":"World Health Organization , 2018. WHO R&D Blueprint: list of blueprint priority diseases. Available from: http:\/\/www.who.int\/blueprint\/priority-diseases\/en\/ [Accessed 24 Mar 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.5","unstructured":"FIND , 2018. Diagnostics for epidemic preparedness: outbreak strategy 2018. Available from: https:\/\/www.finddx.org\/wp-content\/uploads\/2018\/05\/FIND_Outbreak-Strategy_WEB.pdf [Accessed Jun 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijid.2017.11.007","article-title":"The challenges of detecting and responding to a Lassa fever outbreak in an Ebola-affected setting","volume":"66","author":"Hamblion","year":"2018","journal-title":"Int J Infect Dis"},{"key":"2025073015115255000_4.Suppl_2.e001179.7","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat4714","article-title":"Health security\"s blind spot","volume":"359","author":"Berkley","year":"2018","journal-title":"Science"},{"key":"2025073015115255000_4.Suppl_2.e001179.8","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15010096","article-title":"The Zika Virus Epidemic in Brazil: from discovery to future implications","volume":"15","author":"Lowe","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"2025073015115255000_4.Suppl_2.e001179.9","unstructured":"Centers for Disease Control and Prevention (CDC) , 2016. Cost of the ebola epidemic. Available from: https:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/cost-of-ebola.html [Accessed 13 Apr 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1513109"},{"key":"2025073015115255000_4.Suppl_2.e001179.11","first-page":"500","article-title":"Controlling the last known cluster of Ebola virus disease - Liberia, January-February 2015","volume":"64","author":"Nyenswah","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025073015115255000_4.Suppl_2.e001179.12","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-018-05389-2","article-title":"Speedy Ebola tests help contain Africa\"s latest outbreak","volume":"558","author":"Butler","year":"2018","journal-title":"Nature"},{"key":"2025073015115255000_4.Suppl_2.e001179.13","unstructured":"World Health Organization , 2018. Ebola Virus Disease: Democratic Republic of the Congo - External Situation Report 12. Available from: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/272890\/SITREP_EVD_DRC_20180622-eng.pdf?ua=1 [Accessed Jun 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.14","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0140-6736(18)31326-6","article-title":"Response to the Ebola virus disease outbreak in the Democratic Republic of the Congo","volume":"391","author":"Nkengasong","year":"2018","journal-title":"Lancet"},{"key":"2025073015115255000_4.Suppl_2.e001179.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-001114","article-title":"Diagnostic tests for Crimean-Congo haemorrhagic fever: a widespread tickborne disease","volume":"0","author":"Mazzola","year":"2019","journal-title":"BMJ Glob Health"},{"key":"2025073015115255000_4.Suppl_2.e001179.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-001112","article-title":"Diagnostics for filovirus detection: impact of recent outbreaks on the diagnostic landscape","volume":"0","author":"Emperador","year":"2019","journal-title":"BMJ Glob Health"},{"key":"2025073015115255000_4.Suppl_2.e001179.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-001118","article-title":"Diagnostics for Nipah virus: a zoonotic pathogen endemic to Southeast Asia","volume":"0","author":"Mazzola","year":"2019","journal-title":"BMJ Glob Health"},{"key":"2025073015115255000_4.Suppl_2.e001179.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-001105","article-title":"An updated roadmap for MERS-CoV research and product development: focus on diagnostics","volume":"0","author":"Kelly-Cirino","year":"2019","journal-title":"BMJ Glob Health"},{"key":"2025073015115255000_4.Suppl_2.e001179.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-001116","article-title":"Diagnostics for Lassa fever virus: A genetically diverse pathogen found in low-resource settings","volume":"0","author":"Mazzola","year":"2019","journal-title":"BMJ Glob Health"},{"key":"2025073015115255000_4.Suppl_2.e001179.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1606997"},{"key":"2025073015115255000_4.Suppl_2.e001179.21","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/S0140-6736(18)31315-1","article-title":"Deploying RDTs in the DRC Ebola outbreak","volume":"391","author":"Dhillon","year":"2018","journal-title":"Lancet"},{"key":"2025073015115255000_4.Suppl_2.e001179.22","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/S0140-6736(18)30459-8","article-title":"Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutions","volume":"391","author":"Sayed","year":"2018","journal-title":"Lancet"},{"key":"2025073015115255000_4.Suppl_2.e001179.23","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.06.020703","article-title":"Ebola research funding: a systematic analysis, 1997-2015","volume":"6","author":"Fitchett","year":"2016","journal-title":"J Glob Health"},{"key":"2025073015115255000_4.Suppl_2.e001179.24","unstructured":"World Health Organization , 2018. Ebola | Additional documents: Public Reports: WHO list of IVDs for Ebola virus disease accepted for procurement through the EUAL Procedure for IVDs. Available from: http:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/ebola-additional-documents\/en\/ [Accessed 8 May 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.25","unstructured":"US Food and Drug Administration (FDA) , 2018. Emergency use authorizations: 2014 ebola virus emergency use authorizations. Available from: https:\/\/www.fda.gov\/MedicalDevices\/Safety\/EmergencySituations\/ucm161496.htm#ebola [Accessed 8 May 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.26","unstructured":"Gavi , 2017. Gavi \"effective and fit for purpose\". Available from: https:\/\/www.gavi.org\/library\/news\/statements\/2017\/gavi-effective-and-fit-for-purpose-\/ [Accessed 14 Apr 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1502918"},{"key":"2025073015115255000_4.Suppl_2.e001179.28","first-page":"509","article-title":"The laboratory health system and its response to the Ebola virus disease outbreak in Liberia","volume":"5","author":"Kennedy","year":"2016","journal-title":"Afr J Lab Med"},{"key":"2025073015115255000_4.Suppl_2.e001179.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1603734"},{"key":"2025073015115255000_4.Suppl_2.e001179.30","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1038\/emi.2017.42","article-title":"Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology","volume":"6","author":"Priyamvada","year":"2017","journal-title":"Emerg Microbes Infect"},{"key":"2025073015115255000_4.Suppl_2.e001179.31","unstructured":"World Health Organization , 2018. Pandemic Influenza Preparedness (PIP) framework. Available from: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/260538\/WHO-WHE-IHM-PIP-2018.1-eng.pdf;jsessionid=BA5040CD311DA272ECBF67077F2FFCAB?sequence=1 [Accessed 4 Apr 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.32","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05016-11"},{"key":"2025073015115255000_4.Suppl_2.e001179.33","unstructured":"Infectious Disease Research Institute (IDRI) , 2018. Leishmaniasis diagnostics. Available from: http:\/\/www.idri.org\/products\/diagnostics\/ [Accessed 13 Apr 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.34","doi-asserted-by":"crossref","DOI":"10.1038\/nature.2017.22545","article-title":"Massive Ebola data site planned to combat outbreaks","volume":"549","author":"Maxmen","year":"2017","journal-title":"Nature"},{"key":"2025073015115255000_4.Suppl_2.e001179.35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002109","article-title":"Make data sharing routine to prepare for public health emergencies","volume":"13","author":"Chretien","year":"2016","journal-title":"PLoS Med"},{"key":"2025073015115255000_4.Suppl_2.e001179.36","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir046"},{"key":"2025073015115255000_4.Suppl_2.e001179.37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003257","article-title":"The global one health paradigm: challenges and opportunities for tackling infectious diseases at the human, animal, and environment interface in low-resource settings","volume":"8","author":"Gebreyes","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2025073015115255000_4.Suppl_2.e001179.38","unstructured":"World Health Organization , 2013. Crimean-Congo haemorrhagic fever fact sheet. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs208\/en\/ [Accessed 27 Mar 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.39","first-page":"437","article-title":"Outbreak news. Cholera, Haiti, cholera, Pakistan, Crimean-Congo haemorrhagic fever (CCHF) and dengue fever, Pakistan","volume":"85","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"2025073015115255000_4.Suppl_2.e001179.40","unstructured":"World Health Organization , 2018. Ebola virus disease fact sheet. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs103\/en\/ [Accessed 27 Mar 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.41","unstructured":"World Health Organization , 2017. Marburg virus disease fact sheet. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs_marburg\/en\/ [Accessed 27 Mar 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.42","unstructured":"World Health Organization , 2017. Marburg virus disease \u2013 Uganda and Kenya. Available from: http:\/\/www.who.int\/csr\/don\/15-november-2017-marburg-uganda-kenya\/en\/ [Accessed 27 Mar 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.43","unstructured":"World Health Organization , 2017. Lassa fever fact sheet. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs179\/en\/ [Accessed 27 Mar 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.44","unstructured":"World Health Organization , 2018. Lassa fever - Nigeria. Available from: http:\/\/www.who.int\/csr\/don\/23-march-2018-lassa-fever-nigeria\/en\/ [Accessed 27 Mar 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.45","unstructured":"World Health Organization , 2018. Middle East respiratory syndrome coronavirus (MERS-CoV) fact sheet. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/mers-cov\/en\/ [Accessed 27 Mar 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.46","unstructured":"World Health Organization , 2018. MERS-CoV: disease outbreak news. Available from: http:\/\/www.who.int\/csr\/don\/archive\/disease\/coronavirus_infections\/en\/ [Accessed 27 Mar 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.47","unstructured":"Centers for Disease Control and Prevention (CDC) , 2017. Severe acute respiratory syndrome. Available from: https:\/\/www.cdc.gov\/sars\/about\/fs-SARS.pdf [Accessed 27 Mar 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.48","unstructured":"Centers for Disease Control and Prevention (CDC) , 2014. Nipah Virus (NiV). Available from: https:\/\/www.cdc.gov\/vhf\/nipah\/index.html [Accessed 27 Mar 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.49","unstructured":"World Health Organization , 2004. Nipah virus in Bangladesh. Available from: http:\/\/www.who.int\/csr\/don\/2004_04_20\/en\/ [Accessed 27 Mar 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.50","unstructured":"World Health Organization , 2018. Nipah virus: disease outbreak news. Available from: http:\/\/www.who.int\/csr\/don\/31-may-2018-nipah-virus-india\/en\/ [Accessed Jun 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.51","unstructured":"World Health Organization , 2017. Rift Valley fever fact sheet. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs207\/en\/ [Accessed 27 Mar 2018]."},{"key":"2025073015115255000_4.Suppl_2.e001179.52","unstructured":"World Health Organization , 2016. Zika virus fact sheet. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/zika\/en\/ [Accessed 27 Mar 2018]."}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2018-001179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T22:12:02Z","timestamp":1753913522000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2018-001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":52,"journal-issue":{"issue":"Suppl 2","published-online":{"date-parts":[[2019,1,29]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1136\/bmjgh-2018-001179"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2018-001179","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]}}}